Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Non-cash Items (2017 - 2018)

Denali Therapeutics (DNLI) has disclosed Non-cash Items for 2 consecutive years, with $95.8 million as the latest value for Q1 2018.

  • Quarterly Non-cash Items changed N/A to $95.8 million in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $95.8 million through Mar 2018, changed N/A year-over-year, with the annual reading at $77.3 million for FY2017, N/A changed from the prior year.
  • Non-cash Items for Q1 2018 was $95.8 million at Denali Therapeutics, up from $77.3 million in the prior quarter.
  • The five-year high for Non-cash Items was $95.8 million in Q1 2018, with the low at $77.3 million in Q4 2017.